Interestingly, " how long do you think Covid testing will be required", is only part of the question.
As you said, investment based on EuGeni roll-out, but in the short/medium term, EuGeni will have a suite of different tests that is not just Covid-19 related, therefore, IMO the longer term or the more sustainable question should be:
How many other addressable conditions/virus/market can EuGeni serve?
EuGeni's RAT is just one of many.
Ann: TGA Registration Update, page-137
-
- There are more pages in this discussion • 2,281 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.2¢ |
Change
-0.002(6.52%) |
Mkt cap ! $57.26M | |||
| Open | High | Low | Value | Volume |
| 2.3¢ | 2.3¢ | 2.1¢ | $1.664K | 78.11K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 1793889 | 2.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.2¢ | 12544 | 2 |
View Market Depth
| Last trade - 12.41pm 17/09/2024 (20 minute delay) ? |
| ADO (ASX) Chart |